Recommended

Novo Nordisk invests €500m in oral GLP-1 manufacturing
New webinar | Optimising efficiency and yield through bioprocessing automation | 13 May at 3PM | REGISTER NOW!
Moderna’s mCombriax vaccine potential EU approval
WEBINAR | Harnessing AI for more efficient clinical trials | REGISTER TODAY
Ayvakit potential long-term treatment in indolent systemic mastocytosis
UCB invests $1.1bn in immunology with Antengene collaboration
Biogen/Stoke’s zorevunersen shines in clinical readout
Sanofi and Sino Biopharma collaborate in $1.5bn licensing deal
LAST CHANCE TO REGISTER | Harnessing digital PCR for rapid sterility testing
Practical steps for innovating pharmaceutical manufacturing
Advertorial

CPHI to return to Milan in 2024

6
SHARES

CPHI, the global pharmaceutical exhibition will take place in Milan, Italy from 8-10 October 2024.

CPHI Milan

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024.

 

LAST CHANCE TO REGISTER!


Rapid sterility testing is no longer optional for advanced therapies – it’s becoming operationally essential. Join this webinar to explore rapid sterility testing methods that ensure fast, reliable product release, addressing critical challenges in timely delivery and safety.

Harnessing digital PCR for rapid sterility testing

18 March 2026 | 3PM

What you’ll discover:

  • Rapid sterility testing methods that address the challenge of lengthy testing times, improving efficiency and ensuring timely product release
  • Insights into how digital PCR technology enhances testing accuracy and sensitivity, detecting contaminants quickly and reliably
  • Real-world case studies on rapid testing implementations in the field of cell and gene therapy

The session will discuss future trends in sterility testing and showcase successful rapid sterility testing in cell and gene therapy products, demonstrating practical applications and benefits.

Register now to join the discussion

The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region.

Italy is one of Europe’s largest producers and exporters of ingredients – exporting around 85 percent  to North America, the EU and Japan, according to CPHI research. The Milan region is at the centre of Italy’s pharmaceutical base, with over 50 facilities in the Lombardy region alone.

The annual CPHI event is the most comprehensive reference point for the global pharmaceutical industry and is the ideal platform to build networks, meet existing partners, and learn about the latest trends.  

The 2024 event is expected to see a record attendance, with a large number of international visitors and a rapid increase in attendees from the major Asian pharma hubs.

“Fiera Milano is the ideal venue for a global event like CPHI, which is an important tenet of this industry and central to the world economy, with the Lombardy region being a leading producer of pharmaceuticals,” commented Roberto Foresti, deputy general manager of Fiera Milano.

Over the three event days, Fiera Milano will become a hub for the world of pharmaceutical research, development and manufacturing, empowering the industry with partnerships to launch new and better therapies for patients globally.

“We are delighted to be returning to Fiera Milano, as Italy and the Lombardy region are widely known as one of the key pharma manufacturing centres in Europe. There are very few global locations with such a depth and breadth of local and regional talent,” stated Adam Andersen Executive Vice President, Pharma at Informa. “We expect a large international attendance and will marry this with local and regional manufacturing insights.”

This year CPHI takes place in Barcelona, Spain on 24-26 October 2023. This year’s event marks the 20th anniversary of the CPHI Pharma Awards.

 

 
Share via
Share via